BINCY SAMUEL: Open Payments
NPI 1376054775 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$581 in 32 payments from 9 companies in 2025. Trend: 2023 $163 · 2024 $561 · 2025 $581
Food & beverage: $581
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 7 | $170 |
| Otsuka America Pharmaceutical, Inc. | 11 | $170 |
| Lilly USA, LLC | 3 | $54 |
| Biogen, Inc. | 3 | $48 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Sumitomo Pharma America, Inc. | 2 | $33 |
| Lundbeck LLC | 2 | $32 |
| Life Molecular Imaging Ltd | 1 | $24 |
| Exact Sciences Corporation | 1 | $14 |
Products named: Leqembi, REXULTI, AMYVID, SHINGRIX, GEMTESA, NEURACEQ, Cologuard Collection Kit.
Industry payments across TX — which companies pay providers there.
